Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2024)
Top healthcare stocks in 2024 ranked by overall Zen Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Score Price Valuation Financials Forecast Earnings & Revenue Dividends Ownership

Ticker	Company	Country	Market Cap	Shares	Institutional %	Insider %	Net Insider (L12M)	Net Insider (L3M)
AXSM	AXSOME THERAPEUTICS INC	United States	$3.54B	47,374,375	71.00%	29.00%	Net Selling	Net Buying
EHC	ENCOMPASS HEALTH CORP	United States	$8.38B	100,685,317	93.90%	6.10%	Net Selling	Net Selling
TLRY	TILRAY BRANDS INC	Canada	$1.63B	774,028,558	8.97%	1.99%	Net Buying
HQY	HEALTHEQUITY INC	United States	$6.77B	86,158,631	61.02%	38.98%	Net Selling	Net Selling
ARGX	ARGENX SE	Belgium	$22.98B	59,194,488	55.29%	0.00%
MRUS	MERUS NV	Netherlands	$2.80B	57,878,284	87.00%	13.00%	Net Selling
MHUA	MEIHUA INTERNATIONAL MEDICAL TECHNOLOGIES CO LTD	China	$16.35M	23,940,000	1.22%	0.00%
SLGL	SOL-GEL TECHNOLOGIES LTD	Israel	$23.68M	27,857,620	28.59%	0.00%
COO	COOPER COMPANIES INC	United States	$18.02B	198,756,284	24.31%	0.86%	Net Selling	Net Selling
FUSN	FUSION PHARMACEUTICALS INC	Canada	$1.82B	84,692,585	71.20%	28.80%
FATE	FATE THERAPEUTICS INC	United States	$402.90M	99,237,508	61.86%	38.14%	Net Selling	Net Selling
ACIU	AC IMMUNE SA	Switzerland	$237.08M	99,197,829	29.88%	0.00%
XBIO	XENETIC BIOSCIENCES INC	United States	$6.58M	1,540,684	0.42%	99.58%
ZOM	ZOMEDICA CORP	United States	$142.09M	979,949,668	8.89%	6.87%	Net Buying
RXST	RXSIGHT INC	United States	$2.28B	36,987,556	70.19%	29.81%	Net Selling	Net Selling
MRK	MERCK & CO INC	United States	$322.94B	2,532,643,872	76.17%	0.19%	Net Buying	Net Selling
AGL	AGILON HEALTH INC	United States	$1.98B	409,541,664	80.79%	19.21%	Net Selling	Net Selling
CVRX	CVRX INC	United States	$192.95M	20,927,729	36.38%	63.62%	Net Buying	Net Buying
DCPH	DECIPHERA PHARMACEUTICALS INC	United States	$2.05B	80,800,062	67.07%	32.93%	Net Buying	Net Buying
ZVRA	ZEVRA THERAPEUTICS INC	United States	$208.88M	43,426,186	29.20%	27.84%	Net Buying
VERV	VERVE THERAPEUTICS INC	United States	$536.00M	83,619,279	62.25%	37.75%	Net Buying	Net Selling
LH	LABORATORY CORP OF AMERICA HOLDINGS	United States	$16.97B	84,293,628	95.55%	1.52%	Net Selling	Net Selling
MRKR	MARKER THERAPEUTICS INC	United States	$37.57M	8,902,897	1.30%	98.70%
CLNN	CLENE INC	United States	$55.87M	128,430,098	9.06%	52.69%	Net Buying	Net Selling
JANX	JANUX THERAPEUTICS INC	United States	$3.35B	51,660,060	54.14%	45.86%	Net Buying
AMS	AMERICAN SHARED HOSPITAL SERVICES	United States	$18.80M	6,330,000	16.56%	83.44%
AMGN	AMGEN INC	United States	$166.99B	536,434,692	76.42%	1.00%	Net Selling	Net Selling
MASI	MASIMO CORP	United States	$7.25B	52,913,166	83.93%	16.07%	Net Buying	Net Buying
FLGT	FULGENT GENETICS INC	United States	$643.37M	29,924,288	41.31%	58.69%	Net Selling	Net Selling
WAT	WATERS CORP	United States	$19.02B	59,202,626	92.46%	7.54%	Net Selling	Net Selling
IGMS	IGM BIOSCIENCES INC	United States	$591.98M	58,786,588	37.27%	54.63%	Net Buying	Net Buying
AEMD	AETHLON MEDICAL INC	United States	$3.64M	2,620,399	0.16%	99.84%	Net Buying	Net Buying
TRAW	TRAWS PHARMA INC	United States	$13.38M	21,040,645	5.95%	94.05%	Net Selling	Net Selling
MTD	METTLER TOLEDO INTERNATIONAL INC	United States	$26.89B	21,478,705	94.58%	4.52%	Net Selling	Net Buying
NYXH	NYXOAH SA	Belgium	$279.86M	28,673,985	7.33%	0.00%
PROC	PROCAPS GROUP SA	Luxembourg	$318.16M	112,824,183	0.22%	76.27%
CALT	CALLIDITAS THERAPEUTICS AB	Sweden	$595.80M	59,580,087	1.42%	0.00%
ITOS	ITEOS THERAPEUTICS INC	United States	$417.93M	35,843,131	62.37%	37.63%	Net Selling
BRNS	BARINTHUS BIOTHERAPEUTICS PLC	United Kingdom	$84.85M	38,921,212	24.97%	54.37%	Net Buying
SERA	SERA PROGNOSTICS INC	United States	$351.82M	32,425,661	34.04%	21.12%	Net Selling	Net Selling
SPRY	ARS PHARMACEUTICALS INC	United States	$940.89M	96,501,554	43.67%	56.33%	Net Buying	Net Buying
TOI	ONCOLOGY INSTITUTE INC	United States	$79.51M	74,312,921	24.73%	58.31%	Net Selling
RVMD	REVOLUTION MEDICINES INC	United States	$6.62B	164,690,408	89.46%	10.54%	Net Selling	Net Selling
CSTL	CASTLE BIOSCIENCES INC	United States	$671.68M	27,607,183	84.19%	15.81%	Net Selling	Net Selling
HCSG	HEALTHCARE SERVICES GROUP INC	United States	$796.85M	73,646,450	95.48%	4.52%	Net Buying	Net Buying
SPRB	SPRUCE BIOSCIENCES INC	United States	$30.61M	41,149,160	63.59%	36.41%	Net Selling	Net Selling
EYPT	EYEPOINT PHARMACEUTICALS INC	United States	$983.66M	49,830,792	20.11%	79.89%	Net Selling	Net Buying
TECH	BIO-TECHNE CORP	United States	$12.15B	157,191,685	97.66%	2.34%	Net Buying	Net Selling
NNOX	NANO-X IMAGING LTD	Israel	$539.94M	57,778,628	22.32%	0.00%
ALT	ALTIMMUNE INC	United States	$517.54M	70,895,286	34.70%	65.30%	Net Selling
RCEL	AVITA MEDICAL INC	United States	$224.93M	25,706,662	27.60%	3.35%	Net Buying	Net Buying
RYTM	RHYTHM PHARMACEUTICALS INC	United States	$2.63B	60,140,495	87.96%	12.04%	Net Selling	Net Selling
PRE	PRENETICS GLOBAL LTD	Hong Kong	$63.83M	12,205,200	10.04%	0.00%
TMDX	TRANSMEDICS GROUP INC	United States	$4.22B	32,937,296	78.07%	21.93%	Net Selling	Net Selling
OTRK	ONTRAK INC	United States	$11.25M	47,667,342	1.19%	98.81%	Net Buying
SBFM	SUNSHINE BIOPHARMA INC	Canada	$835.40k	994,529	40.70%	59.30%	Net Buying	Net Buying
CDIO	CARDIO DIAGNOSTICS HOLDINGS INC	United States	$16.56M	21,591,119	7.67%	34.34%	Net Buying	Net Buying
TXG	10X GENOMICS INC	United States	$3.29B	119,708,426	80.11%	15.45%	Net Buying	Net Selling
IART	INTEGRA LIFESCIENCES HOLDINGS CORP	United States	$2.26B	78,219,780	64.83%	35.17%	Net Selling	Net Selling
BGNE	BEIGENE LTD	Cayman Islands	$16.98B	1,359,513,224	3.31%	34.70%	Net Selling	Net Selling
PLRX	PLIANT THERAPEUTICS INC	United States	$842.14M	60,239,176	70.74%	29.26%	Net Selling
INNV	INNOVAGE HOLDING CORP	United States	$549.03M	135,899,435	4.67%	95.33%	Net Selling	Net Selling
IQV	IQVIA HOLDINGS INC	United States	$40.70B	182,200,000	53.95%	46.05%	Net Selling	Net Selling
SAGE	SAGE THERAPEUTICS INC	United States	$838.94M	60,182,031	71.61%	28.39%	Net Selling
LXRX	LEXICON PHARMACEUTICALS INC	United States	$428.45M	246,236,753	21.34%	78.66%	Net Buying	Net Buying
IMCR	IMMUNOCORE HOLDINGS PLC	United Kingdom	$3.00B	49,820,613	75.26%	0.07%	Net Buying	Net Buying
VCYT	VERACYTE INC	United States	$1.53B	75,067,823	64.44%	35.56%	Net Selling	Net Selling
ZLAB	ZAI LAB LTD	China	$1.61B	992,087,430	4.15%	1.96%	Net Buying	Net Buying
OCS	OCULIS HOLDING AG	Switzerland	$469.12M	36,649,705	10.87%	0.00%
VRDN	VIRIDIAN THERAPEUTICS INC	United States	$966.62M	62,767,570	67.46%	32.54%	Net Buying
EDAP	EDAP TMS SA	France	$264.92M	37,103,779	42.93%	0.00%
CMRX	CHIMERIX INC	United States	$85.42M	89,629,902	45.21%	31.76%	Net Buying	Net Selling
APRE	APREA THERAPEUTICS INC	United States	$29.05M	5,430,215	1.54%	98.46%	Net Buying	Net Buying
QSI	QUANTUM-SI INC	United States	$260.86M	141,769,917	36.43%	63.57%	Net Buying	Net Buying
IFRX	INFLARX NV	Germany	$81.26M	58,883,272	29.00%	0.00%
IMTX	IMMATICS NV	Germany	$911.76M	84,657,789	58.58%	0.00%
MREO	MEREO BIOPHARMA GROUP PLC	United Kingdom	$457.24M	701,287,029	11.20%	4.59%
KRRO	KORRO BIO INC	United States	$467.20M	8,021,946	18.90%	81.10%	Net Buying	Net Buying
AXGN	AXOGEN INC	United States	$253.05M	43,704,574	54.13%	45.87%	Net Selling	Net Selling
RGEN	REPLIGEN CORP	United States	$9.33B	55,875,894	73.41%	26.59%	Net Selling	Net Selling
BEAM	BEAM THERAPEUTICS INC	United States	$1.89B	81,657,714	78.56%	21.44%	Net Selling	Net Selling
OPRX	OPTIMIZERX CORP	United States	$193.11M	18,183,914	52.76%	47.24%	Net Selling	Net Selling
PSNL	PERSONALIS INC	United States	$77.78M	50,503,889	43.52%	18.38%	Net Selling	Net Buying
NRBO	NEUROBO PHARMACEUTICALS INC	United States	$18.54M	4,906,032	0.25%	99.75%
ALHC	ALIGNMENT HEALTHCARE INC	United States	$1.27B	191,198,265	31.34%	68.66%	Net Selling	Net Selling
CASI	CASI PHARMACEUTICALS INC	China	$37.39M	13,378,175	0.35%	99.65%
LQDA	LIQUIDIA CORP	United States	$972.40M	76,027,776	37.70%	62.30%	Net Buying	Net Selling
LUNG	PULMONX CORP	United States	$381.17M	38,815,760	86.31%	13.69%	Net Selling	Net Selling
PRPO	PRECIPIO INC	United States	$8.30M	1,430,292	0.61%	99.39%	Net Buying	Net Buying
CTKB	CYTEK BIOSCIENCES INC	United States	$813.73M	130,824,069	60.34%	21.49%	Net Selling	Net Selling
SRDX	SURMODICS INC	United States	$463.31M	14,260,000	62.61%	37.39%	Net Selling	Net Buying
GRFS	GRIFOLS SA	United States	$4.52B	687,554,908	17.73%	0.00%
ACB	AURORA CANNABIS INC	Canada	$320.76M	47,590,382	54.59%	0.00%
YMAB	Y-MABS THERAPEUTICS INC	United States	$750.78M	43,777,105	46.22%	39.32%	Net Buying	Net Selling
BLUE	BLUEBIRD BIO INC	United States	$98.40M	109,336,211	91.17%	8.83%	Net Selling	Net Selling
EMBC	EMBECTA CORP	United States	$584.43M	57,578,921	96.14%	1.52%	Net Selling	Net Selling
ELMD	ELECTROMED INC	United States	$159.20M	8,605,227	19.72%	80.28%	Net Buying	Net Buying
SILK	SILK ROAD MEDICAL INC	United States	$794.46M	39,174,619	83.32%	16.68%	Net Selling	Net Selling
HLTH	CUE HEALTH INC	United States	$22.19M	158,516,303	38.15%	55.22%	Net Selling	Net Selling
CRBU	CARIBOU BIOSCIENCES INC	United States	$340.49M	90,314,501	76.47%	8.74%	Net Buying	Net Buying

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	681	+1.07%	+6.00%	-2.53%	-18.30%	6.05x	6.01x	+14.40%	+2.29%	-33.91%	+80.46%	Strong Buy
Diagnostics & Research	66	+0.85%	+0.70%	-4.26%	-0.73%	38.44x	4.21x	-23.57%	+6.35%	+11.16%	+10.51%	Buy
Drug Manufacturers - General	17	+0.84%	+2.91%	-0.54%	+12.68%	148.07x	6.24x	+33.79%	+8.12%	+14.24%	+13.81%	Buy
Drug Manufacturers - Specialty & Generic	90	-0.21%	+4.09%	+0.45%	-3.63%	33.76x	2.15x	+11.91%	+3.10%	+5.65%	+32.15%	Strong Buy
Healthcare Plans	12	+0.01%	-1.01%	-0.15%	-0.05%	19.70x	2.90x	+19.64%	+6.04%	+14.10%	+17.24%	Buy
Health Information Services	61	+0.46%	+1.33%	-3.77%	-22.81%	75.59x	3.24x	+6.63%	+2.09%	+5.13%	+34.77%	Buy
Medical Care Facilities	51	+0.10%	+2.08%	-4.18%	+7.39%	-7.32x	4.34x	-93.77%	+6.64%	+13.89%	+17.87%	Buy
Medical Devices	154	+0.93%	+3.67%	-0.50%	-12.74%	27.79x	3.71x	+10.38%	+5.26%	+7.71%	+19.09%	Buy
Medical Distribution	9	-1.40%	-4.69%	-6.08%	+30.95%	26.17x	109.10x	-8.59%	+3.48%	+18.93%	+10.93%	Buy
Medical Instruments & Supplies	56	+0.43%	+1.57%	-1.02%	-12.24%	56.77x	3.54x	+11.45%	+7.81%	+10.28%	+19.60%	Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in May 2024?

According to Zen Score, the 3 best healthcare stocks to buy right now are:

1. Cross Country Healthcare (NASDAQ:CCRN)

Cross Country Healthcare (NASDAQ:CCRN) is the top healthcare stock with a Zen Score of 70, which is 45 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Cross Country Healthcare has seen its stock lose -22.25% over the past year, underperforming other healthcare stocks by -14 percentage points.

Cross Country Healthcare has an average 1 year price target of $20.25, an upside of 21.48% from Cross Country Healthcare's current stock price of $16.67.

Cross Country Healthcare stock has a consensus Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Cross Country Healthcare, 25% have issued a Strong Buy rating, 25% have issued a Buy, 50% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the second best healthcare stock with a Zen Score of 68, which is 43 points higher than the healthcare sector average of 25. It passed 21 out of 33 due diligence checks and has strong fundamentals. Semler Scientific has seen its stock return 1.39% over the past year, overperforming other healthcare stocks by 10 percentage points.

3. Progyny (NASDAQ:PGNY)

Progyny (NASDAQ:PGNY) is the third best healthcare stock with a Zen Score of 67, which is 42 points higher than the healthcare sector average of 25. It passed 22 out of 33 due diligence checks and has strong fundamentals. Progyny has seen its stock lose -6.98% over the past year, overperforming other healthcare stocks by 1 percentage points.

Progyny has an average 1 year price target of $47.00, an upside of 48.17% from Progyny's current stock price of $31.72.

Progyny stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 4 analysts covering Progyny, 75% have issued a Strong Buy rating, 25% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 72 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Mei Pharma (NASDAQ:MEIP)

Mei Pharma (NASDAQ:MEIP) has an annual dividend yield of 57.19%, which is 54 percentage points higher than the healthcare sector average of 2.79%.

Mei Pharma's dividend payout ratio of 58.9% indicates that its high dividend yield is sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 10.34%, which is 8 percentage points higher than the healthcare sector average of 2.79%.

Siga Technologies's dividend payout ratio of 47.4% indicates that its high dividend yield is sustainable for the long-term.

3. Spok Holdings (NASDAQ:SPOK)

Spok Holdings (NASDAQ:SPOK) has an annual dividend yield of 8.69%, which is 6 percentage points higher than the healthcare sector average of 2.79%. Spok Holdings's dividend payout is not stable, having dropped more than 10% two times in the last 10 years. Spok Holdings's dividend has shown consistent growth over the last 10 years.

Spok Holdings's dividend payout ratio of 148.8% indicates that its high dividend yield might not be sustainable for the long-term.

Why are healthcare stocks up?

Healthcare stocks were up 0.65% in the last day, and up 2.85% over the last week. Twist Bioscience was the among the top gainers in the healthcare sector, gaining 28.74% yesterday.

Twist Bioscience shares are trading higher after the company reported better-than-expected Q2 financial results.

What are the most undervalued healthcare stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare stocks right now are:

1. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the most undervalued healthcare stock based on WallStreetZen's Valuation Score. Inmode has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Inmode's stock has dropped -47.67% in the past year. It has underperformed other stocks in the healthcare sector by -39 percentage points.

2. Pacira Biosciences (NASDAQ:PCRX)

Pacira Biosciences (NASDAQ:PCRX) is the second most undervalued healthcare stock based on WallStreetZen's Valuation Score. Pacira Biosciences has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Pacira Biosciences's stock has dropped -36.9% in the past year. It has underperformed other stocks in the healthcare sector by -28 percentage points.

3. Semler Scientific (NASDAQ:SMLR)

Semler Scientific (NASDAQ:SMLR) is the third most undervalued healthcare stock based on WallStreetZen's Valuation Score. Semler Scientific has a valuation score of 100, which is 84 points higher than the healthcare sector average of 16. It passed 7 out of 7 valuation due diligence checks.

Semler Scientific's stock has gained 1.39% in the past year. It has overperformed other stocks in the healthcare sector by 10 percentage points.

Are healthcare stocks a good buy now?

48.04% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 35.99% over the next year.

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 68.89x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.